CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

NCT07558434 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Severe Aplastic Anemia (SAA)
Transfusion-dependent Non-severe Aplastic Anemia

Interventions

DRUG: Cyclosporine (CsA)
DRUG: thrombopoietin receptor agonist (TPO-RA)
DRUG: Romiplostim N01

Sponsor

Peking Union Medical College Hospital